Jim joined Maverick in 2017 from Pacira Pharmaceuticals, Inc., where as President he oversaw global R&D, manufacturing and capacity expansion activities, as well as commercial and medical support activities. He joined Pacira as Chief Financial Officer in 2008 and led the company’s 2011 IPO and subsequent debt and equity financings. Prior to that, Jim was an executive with Bioenvision Inc. (Nasdaq: BIVN), a commercial stage oncology company acquired by Genzyme, and Merrimack Pharmaceuticals, an oncology-focused systems biology company. Earlier in his career he spent over a decade in investment banking where he was responsible for sourcing and executing transactions for a broad base of public and private healthcare and life sciences companies.
Jim serves on the Board of Matinas BioPharm and Aquestive Therapeutics.
Jim received a Bachelor of Science in Physics from Wake Forest University and his MBA from the University of Michigan.
Disruptive Technologies Creating Revolutionary Opportunities
1:00 PM - 2:15 PM